Complementary arguments in favor of the betacytotrophic action of the hypglycemic sulfonamides.

Suppr

超能文献

作者信息

Loubatières A L

出版信息

Adv Metab Disord. 1970;1:Suppl 1:411+. doi: 10.1016/b978-0-12-027361-4.50048-x.

DOI:10.1016/b978-0-12-027361-4.50048-x

PMID:4911189

Abstract

摘要

相似文献

Complementary arguments in favor of the betacytotrophic action of the hypglycemic sulfonamides.

Adv Metab Disord. 1970;1:Suppl 1:411+. doi: 10.1016/b978-0-12-027361-4.50048-x.

[Physiological and pharmacological aspects of the central role of the pancreas in the mode of action of hypoglycemic sulfonamides].

Acta Diabetol Lat. 1969 Sep;6 Suppl 1:216-55.

Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).

Acta Diabetol Lat. 1973 Mar-Apr;10(2):261-82.

[The present status of the question of the mechanism of action of sulfanilamide hypoglycemic preparations and several aspects of their use in the treatment of diabetes mellitus].

Probl Endokrinol (Mosk). 1971 Sep-Oct;17(5):121-5.

[A morphological study on the mechanism of insulin-release, using sulfonylurea, l-leucine, and alpha-ketocarboxylic acids].

Nihon Naibunpi Gakkai Zasshi. 1968 Oct 20;44(7):741-9. doi: 10.1507/endocrine1927.44.7_741.

[Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].

Probl Endokrinol (Mosk). 1985 Mar-Apr;31(2):76-85.

[Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].

Journ Annu Diabetol Hotel Dieu. 1972;13(0):55-65.

[Experimental study on glibenclamide (HB 419), a new particularly active hypoglycaemic sulphonamide. II. Betacytotrophic action and stimulation of the neogenesis of the islets of Langerhans].

Diabetologia. 1969 Aug;5(4):219-27. doi: 10.1007/BF01212088.

[Pathophysiology of diabetes mellitus type 2 and the mechanism of action and indications for using hypoglycemic sulfonylurea derivatives].

Pol Tyg Lek. 1985 May 6;40(18):505-11.

[Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].

Arzneimittelforschung. 1969 Aug;19(8):Suppl:1354-63.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验